IRIS Institutional Research Information System - OPENBS Open Archive UniBS

ADAMO, Marianna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.818
AS - Asia 7.804
EU - Europa 3.720
SA - Sud America 1.950
AF - Africa 209
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 21.521
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.563
SG - Singapore 2.956
CN - Cina 1.863
BR - Brasile 1.648
HK - Hong Kong 1.259
IT - Italia 806
VN - Vietnam 626
DE - Germania 590
RU - Federazione Russa 377
FR - Francia 361
GB - Regno Unito 355
FI - Finlandia 321
TR - Turchia 305
UA - Ucraina 201
IN - India 199
IE - Irlanda 170
BD - Bangladesh 124
CA - Canada 124
AR - Argentina 115
MX - Messico 81
PL - Polonia 80
NL - Olanda 79
IQ - Iraq 76
ZA - Sudafrica 76
JP - Giappone 67
AT - Austria 65
SE - Svezia 65
CZ - Repubblica Ceca 60
ES - Italia 55
ID - Indonesia 51
SA - Arabia Saudita 48
EC - Ecuador 46
PK - Pakistan 39
VE - Venezuela 37
MA - Marocco 32
CO - Colombia 30
UZ - Uzbekistan 26
BE - Belgio 25
PY - Paraguay 23
CL - Cile 22
KE - Kenya 22
TN - Tunisia 22
EG - Egitto 17
AE - Emirati Arabi Uniti 16
PH - Filippine 16
JO - Giordania 13
NP - Nepal 13
PE - Perù 13
SC - Seychelles 13
IL - Israele 12
LT - Lituania 12
BG - Bulgaria 11
AU - Australia 10
CH - Svizzera 10
MY - Malesia 10
TT - Trinidad e Tobago 10
UY - Uruguay 10
HN - Honduras 9
LV - Lettonia 9
AZ - Azerbaigian 8
GR - Grecia 8
KZ - Kazakistan 8
DZ - Algeria 7
IR - Iran 7
JM - Giamaica 7
KR - Corea 7
PA - Panama 7
PT - Portogallo 7
TH - Thailandia 7
HU - Ungheria 6
LB - Libano 6
PS - Palestinian Territory 6
RO - Romania 6
AL - Albania 5
BO - Bolivia 5
ET - Etiopia 5
MD - Moldavia 5
RS - Serbia 5
TW - Taiwan 5
CY - Cipro 4
EU - Europa 4
NG - Nigeria 4
NO - Norvegia 4
OM - Oman 4
AM - Armenia 3
BB - Barbados 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
KG - Kirghizistan 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CM - Camerun 2
CR - Costa Rica 2
DM - Dominica 2
EE - Estonia 2
Totale 21.482
Salva come PNG Salva come JPEG
Città #
Singapore 1.445
Hong Kong 1.253
Ashburn 882
Beijing 567
The Dalles 528
San Jose 524
Chandler 449
Fairfield 365
Los Angeles 315
New York 313
Lauterbourg 271
Istanbul 241
Princeton 238
Ho Chi Minh City 224
Helsinki 222
Houston 192
Dublin 170
Woodbridge 166
Seattle 165
São Paulo 150
Munich 146
Milan 145
Wilmington 142
Moscow 136
Cambridge 131
Dallas 129
Buffalo 127
Redondo Beach 125
Jacksonville 119
Hanoi 117
Chicago 103
Shanghai 94
Romola 89
Council Bluffs 81
Frankfurt am Main 80
Ann Arbor 73
Orem 72
San Francisco 70
London 66
Warsaw 64
Tokyo 58
Montreal 51
Nuremberg 51
Santa Clara 50
Atlanta 46
Chennai 46
Lappeenranta 46
Rome 46
Brescia 45
Rio de Janeiro 45
Turku 45
Brno 44
Brooklyn 44
Denver 43
Johannesburg 43
Poplar 40
Des Moines 38
Boardman 36
Guangzhou 36
Boston 35
Stockholm 35
Toronto 33
Belo Horizonte 32
Brasília 31
Haiphong 30
San Diego 30
Amsterdam 29
Düsseldorf 29
Vienna 29
Phoenix 27
Pune 26
Brussels 25
Charlotte 24
Curitiba 24
Hangzhou 24
Da Nang 23
Salt Lake City 23
Kyiv 22
Salvador 22
Ankara 21
Mexico City 21
Mumbai 21
Porto Alegre 21
Tashkent 21
Changsha 20
Manchester 20
Riyadh 20
Baghdad 19
Brindisi 19
Buenos Aires 19
Nairobi 19
Biên Hòa 18
Dhaka 18
Erbil 18
Washington 18
Nanjing 17
Quito 17
New Delhi 16
Thái Bình 16
Tianjin 16
Totale 12.590
Salva come PNG Salva come JPEG
Nome #
May 2020 at a glance: ischaemic heart failure and sex-related differences 237
Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience 198
Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry 193
Mitraclip therapy in patients with functional mitral regurgitation and missing leaflet coaptation: is it still an exclusion criterion? 187
Self-expanding transcatheter aortic valve implantation for degenerated small Mitroflow bioprosthesis: Early and midterm outcomes 181
Effectiveness of MitraClip therapy in patients with refractory heart failure 180
Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy 179
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 168
EkoSonic Endovascular System for patients with acute pulmonary embolism and contraindication to systemic fibrinolysis 160
August 2020 at a glance: focus on neurohormonal antagonists and electrolytes 152
2024 update in heart failure 144
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC 139
Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE-HF2 trial and comparison to COAPT and MITRA-FR trials 139
Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19) 117
Prognostic value of right ventricle to pulmonary artery coupling in transcatheter aortic valve implantation recipients 114
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 114
Role of nutrition in heart failure patients 113
Highlights in valvular heart diseases 110
Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care 109
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis 108
Role of different vascular approaches on transcatheter aortic valve implantation outcome: a single-center study. 108
September 2019 at a glance: focus on devices 106
Trans-axillary versus trans - aortic approach for transcatheter aortic valve implantation with corevalve revalving system: insights from multicenter experience 106
Highlights in heart failure 106
April 2020 at a glance: epidemiology, prevention, and biomarkers 106
COVID 19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease 106
Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention? A Pre-Specified Analysis from the ZEUS Trial 106
January 2020 at a glance: translational medicine, predictors of outcome and treatments 105
Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study 104
Changes in Right Ventricular-to-Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation 104
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part II: From preventive strategies to treatment of patients with cardio-renal damage] 104
Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair 104
ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19 104
TRIVALVE Score: A Risk Score for Mortality/Hospitalization Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention 102
December 2019 at a glance: economic burden, co-morbidities, and prognosis 102
Life-saving transcatheter aortic valve implantation for acute severe aortic regurgitation due to rheumatoid arthritis and complicated by cardiogenic shock 102
[RESHAPE-HF2: new evidence and clinical implications] 101
[Italian Society of Cardiology-Italian Society of Nephrology Consensus document: The cardio-renal interaction in the prevention and treatment of cardiovascular diseases - Part I: From cardiovascular risk factors to the mechanisms of cardio-renal syndrome] 100
Atrial fibrillation in the COVID-19 era: Simple bystander or marker of increased risk? 100
Prognostic Value of Pre-operative Atrial Fibrillation in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation 100
[Advances in heart failure treatment: a summary of 50 years of evolution] 99
Congestion in Patients with Advanced Heart Failure: Assessment and Treatment 99
MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry 99
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 98
Transcatheter therapies for tricuspid valve regurgitation 98
Prognostic Impact of Heart Failure History in Patients with Secondary Mitral Regurgitation Treated by MitraClip 98
[2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure] 97
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 97
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC 97
2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry 96
Percutaneous valve repair of functional mitral regurgitation: aiming at optimal and durable results 96
Management of heart failure patients with COVID-19: a joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology 96
Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project 96
A Score to Assess Mortality After Percutaneous Mitral Valve Repair 95
Prediction of mortality and heart failure hospitalisations in patients undergoing M-TEER: external validation of the COAPT risk score 95
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology 94
[Sodium-glucose cotransporter 2 inhibitors and heart failure with preserved ejection fraction: the EMPEROR-Preserved and DELIVER studies] 92
Derivation and Validation of a Clinical Risk Score for COAPT-Ineligible Patients Who Underwent Transcatheter Edge-to-Edge Repair 91
Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge-to-edge repair - Results from the TriValve registry 91
Treatment of functional mitral regurgitation in chronic heart failure: can we get a 'proof of concept' from the MITRA-FR and COAPT trials? 90
Hepatic T1-time, cardiac structure and function and cardiovascular outcomes in patients with dilated cardiomyopathy 90
Transcatheter Edge-to-Edge Repair in COAPT-Ineligible Patients: Incidence and Predictors of 2-Year Good Outcome 90
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 89
Echocardiographic findings in subjects with an amyloidogenic apolipoprotein A1 pathogenic variant 87
Percutaneous treatment of mitral regurgitation: looking for a final model 87
Biologically active adrenomedullin as a marker for residual congestion and early rehospitalization in patients hospitalized for acute heart failure: Data from STRONG-HF 86
Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study 86
2023 focused update of the 2021 ESC heart failure guidelines: Key messages for clinical practice 86
Telemedicine for the treatment of heart failure: new opportunities after COVID-19 85
April 2022 at a glance: focus on prevention, acute heart failure and heart failure with preserved ejection fraction 85
August 2021 at a glance: focus on cardiomyopathies, medical treatment and devices 85
[Transcatheter devices for chronic heart failure: state of the art] 85
April 2021 at a glance: focus on systolic function, quality of life and treatment in heart failure 85
Medical therapy of cardiogenic shock: Contemporary use of inotropes and vasopressors 84
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 84
Quality of life in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: tools and evidence 84
A meta-analysis of MitraClip combined with medical therapy vs. medical therapy alone for treatment of mitral regurgitation in heart failure patients 84
Characteristics and outcomes of patients with tricuspid regurgitation and advanced heart failure 83
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 83
July 2020 at a glance: focus on imaging and cardiomyopathies 83
Impact of Transcatheter Edge-to-Edge Mitral Valve Repair on Guideline-Directed Medical Therapy Uptitration 82
Long-Term Outcomes After Edge-to-Edge Repair of Secondary Mitral Regurgitation: 5-Year Results From the EuroSMR Registry 81
Prognostic value of right ventricular longitudinal strain in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge mitral valve repair 81
Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 81
Cardiac contractility modulation: an effective treatment strategy for heart failure beyond reduced left ventricular ejection fraction? 81
Clinical impact of changes in mitral regurgitation severity after medical therapy optimization in heart failure 81
COVID-19 and Heart Failure: From Epidemiology During the Pandemic to Myocardial Injury, Myocarditis, and Heart Failure Sequelae 81
The Mayo ATTR-CM score versus other diagnostic scores and cardiac biomarkers in patients with suspected cardiac amyloidosis 80
Updates in heart failure: sodium glucose co-transporter 2 inhibitors and beyond - major changes are coming 79
Il dronedarone: in quali pazienti e con quali associazioni? 79
October 2019 at a glance: epidemiology, prevention, and modes of death 79
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 79
Impact of mitral regurgitation in patients with worsening heart failure: insights from BIOSTAT-CHF 78
Aiming at harmony. Comparing and contrasting International HFrEF Guidelines 77
September 2020 at a glance: focus on heart failure with preserved ejection fraction and medical therapy 77
Percutaneous Edge-to-Edge Mitral Valve Repair: Beyond the Left Heart 77
Sex differences in pulmonary arterial hypertension: Insights from the FOCUS-PAH registry 76
Effect of Chronic Kidney Disease on 5-Year Outcome in Patients With Heart Failure and Secondary Mitral Regurgitation Undergoing Percutaneous MitraClip Insertion 76
Right ventricular deformation and right ventricular-arterial coupling in patients with heart failure due to severe aortic stenosis undergoing TAVI: long-term results. 76
Renal failure after trans-catheter aortic valve implantation 76
Totale 10.320
Salva come PNG Salva come JPEG
Categoria #
all - tutte 138.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.938
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021233 0 0 0 0 0 0 0 0 0 118 71 44
2021/2022728 23 102 22 83 21 57 15 76 34 51 42 202
2022/20231.347 150 48 20 115 101 377 10 144 201 19 85 77
2023/20242.078 111 39 174 150 117 243 144 62 502 79 81 376
2024/20255.393 46 47 185 502 506 433 572 304 440 607 1.067 684
2025/202610.487 1.148 1.557 898 1.730 1.062 708 1.359 529 790 706 0 0
Totale 21.801